Product Information

ALLOPURINOL 300 MG TABLET is a generic product labeled by Leading Pharma, LLC, priced at $0.0546 per EA under NDC 69315029210. Its NADAC has been published 146 times since Nov 8, 2023.

FDA first approved this application on Mar 7, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Allopurinol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for ALLOPURINOL 300 MG TABLET has been published 146 times since Nov 8, 2023, and over the history we have for it it has declined 23.4%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.